Literature DB >> 33382612

Selective Utilization of the Human Milk Oligosaccharides 2'-Fucosyllactose, 3-Fucosyllactose, and Difucosyllactose by Various Probiotic and Pathogenic Bacteria.

Krista Salli1, Johanna Hirvonen1, Jani Siitonen2, Ilmari Ahonen3, Heli Anglenius1, Johanna Maukonen1.   

Abstract

Prebiotic human milk oligosaccharides (HMOs) are found in human milk, which are not digested by infants but are metabolized by beneficial gut bacteria. We determined the ability of 57 bacterial strains within the Family Lactobacillaceae and genera Bifidobacterium and Bacteroides and potentially pathogenic bacteria to ferment the HMOs 2'-fucosyllactose, 3-fucosyllactose, and difucosyllactose. In addition, prebiotic galacto-oligosaccharides (GOS), lactose, fucose, and glucose were evaluated as carbon sources for these bacterial strains. Bacterial growth was monitored using the automatic Bioscreen C system. Only certain bifidobacteria, such as Bifidobacterium longum subsp. infantis and Bifidobacterium bifidum, as well as Bacteroides fragilis, Bacteroides vulgatus, and Bacteroides thetaiotaomicron utilized the studied HMOs as their sole carbon source, whereas almost all studied bacterial strains were able to utilize GOS, lactose, and glucose. The selectivity in utilization of HMOs by only certain bacteria can be advantageous by promoting beneficial microbes but not supporting the harmful pathogens in contrast to other less selective prebiotics.

Entities:  

Keywords:  bifidobacteria; fucose; galacto-oligosaccharides; human milk oligosaccharides; lactobacilli; potentially pathogenic bacteria

Mesh:

Substances:

Year:  2020        PMID: 33382612     DOI: 10.1021/acs.jafc.0c06041

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  11 in total

1.  2'-Fucosyllactose Increases the Abundance of Blautia in the Presence of Extracellular Fucosidase-Possessing Bacteria.

Authors:  Ayako Horigome; Nanami Hashikura; Keisuke Yoshida; Jin-Zhong Xiao; Toshitaka Odamaki
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

2.  Combining galacto-oligosaccharides and 2'-fucosyllactose alters their fermentation kinetics by infant fecal microbiota and influences AhR-receptor dependent cytokine responses in immature dendritic cells.

Authors:  Renate Akkerman; Madelon J Logtenberg; Martin Beukema; Bart J de Haan; Marijke M Faas; Erwin G Zoetendal; Henk A Schols; Paul de Vos
Journal:  Food Funct       Date:  2022-06-20       Impact factor: 6.317

3.  The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro.

Authors:  Markus J Lehtinen; Ritesh Kumar; Bryan Zabel; Sanna M Mäkelä; Derek Nedveck; Peipei Tang; Sinikka Latvala; Sebastien Guery; Charles R Budinoff
Journal:  iScience       Date:  2022-05-23

4.  In Vitro Probiotic Modulation of the Intestinal Microbiota and 2'Fucosyllactose Consumption in Fecal Cultures from Infants at Two Months of Age.

Authors:  Alicja M Nogacka; Silvia Arboleya; Naghmeh Nikpoor; Jeremie Auger; Nuria Salazar; Isabel Cuesta; Jorge R Alvarez-Buylla; Laura Mantecón; Gonzalo Solís; Miguel Gueimonde; Thomas A Tompkins; Clara G de Los Reyes-Gavilán
Journal:  Microorganisms       Date:  2022-01-29

5.  Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial.

Authors:  Philippe Alliet; Yvan Vandenplas; Paola Roggero; Sabine N J Jespers; Stefaan Peeters; Jean-Philippe Stalens; Guus A M Kortman; Mailis Amico; Bernard Berger; Norbert Sprenger; Colin I Cercamondi; Giovanni Corsello
Journal:  Nutr J       Date:  2022-02-22       Impact factor: 3.271

6.  2'-Fucosyllactose Ameliorates Inflammatory Bowel Disease by Modulating Gut Microbiota and Promoting MUC2 Expression.

Authors:  Qianqian Yao; Linlin Fan; Nan Zheng; Christophe Blecker; Véronique Delcenserie; Huiying Li; Jiaqi Wang
Journal:  Front Nutr       Date:  2022-02-17

7.  The Infant Gut Commensal Bacteroides dorei Presents a Generalized Transcriptional Response to Various Human Milk Oligosaccharides.

Authors:  Sivan Kijner; Avital Cher; Moran Yassour
Journal:  Front Cell Infect Microbiol       Date:  2022-03-18       Impact factor: 5.293

Review 8.  Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications.

Authors:  Marta Potrykus; Sylwia Czaja-Stolc; Marta Stankiewicz; Łukasz Kaska; Sylwia Małgorzewicz
Journal:  Nutrients       Date:  2021-10-28       Impact factor: 5.717

Review 9.  Untangling human milk oligosaccharides and infant gut microbiome.

Authors:  Andrea C Masi; Christopher J Stewart
Journal:  iScience       Date:  2021-12-01

Review 10.  Biology of human milk oligosaccharides: From basic science to clinical evidence.

Authors:  Norbert Sprenger; Hanne L P Tytgat; Aristea Binia; Sean Austin; Atul Singhal
Journal:  J Hum Nutr Diet       Date:  2022-02-02       Impact factor: 2.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.